bioloomics

We are very excited to share the addition of Viswa Colluru, PhD to our advisory board. Viswa is the founder and CEO of Enveda Biosciences, a rapidly growing Biotech company ...

BioLoomics is excited to welcome Dr. Bill Kohlbrenner to the team as Vice President of Business Development. Prior to joining BioLoomics, Bill has had a fruitful career in pharma ...

Join us July 9th and 10th for the KAND Family & Scientific Engagement Conference hosted by KIF1A.ORG. Register here  to join the conversation and learn about the latest research and ...

BioLoomics is joining KIF1A.ORG in its search for a treatment and cure for KIF1A-Associated Neurological Disorder (KAND). We are applying our evolution-in-a-microscope technology to build high throughput drug discovery ...

BioLoomics is forming a Scientific Advisory Board (SAB) to bring together diverse experts to bolster our mission to produce drug discovery assays and the first biosensing biologics with enhanced specificity ...

BioLoomics closed a $575,000 round of seed funding on May 11, 2021. The funds were contributed by private investors, including several investors who participated in the pre-seed round. BioLoomics will ...